WW News & Events

WW International announced a strategic partnership with PVOLVE, the clinically validated workout method, designed to support longevity through strength, mobility, and stability training. "As the definition of weight health evolves, so does our approach," said Julie Rice, Chief Experience Officer of Weight Watchers. "This partnership with PVOLVE builds on our foundation by bringing more strength-forward movement into our ecosystem alongside nutrition, behavior change, coaching, and medical care - so our members can achieve more sustainable, long-term results."

WW International (WW) announced access to Novo Nordisk's (NVO) newly FDA approved oral formulation of Wegovy through its integrated GLP-1 platform. WW said: "The addition of a once-daily Wegovy pill expands access to GLP-1 treatment and reinforces Weight Watchers' leadership in delivering comprehensive care models that help people succeed on medication in real life by pairing medical therapy with evidence-based behavior change and ongoing support."

WW International introduced a new, fully integrated experience that unites GLP-1 prescribing, personalized nutrition, behavioral support, coaching, and community within a redesigned app experience and digital platform. Built for a new era of weight management and long-term health, the new integrated offering delivers coordinated, evidence-based support that adapts to members' lives and helps them achieve-and sustain-superior results. Weight Watchers Med+ is the company's dedicated GLP-1 medical program, providing members access to board-certified physicians and a coordinated care team who specialize in obesity and metabolic health. These clinicians write prescriptions for GLP-1 medications for eligible members and offer ongoing medical guidance throughout treatment. What truly sets Med+ apart is that every member prescribed GLP-1s also receives the full GLP-1 Success experience-a structured behavioral, nutritional, and lifestyle support program that research shows achieves better results on medication. This newly launched GLP-1 Success program is built around the real needs of people using these medications. Members receive personalized nutrition guidance to help them meet important macronutrient goals, tools to track weight loss and medication doses, strategies and support for managing side effects, and strength-building plans to help preserve muscle mass. The program also provides access to expert coaches trained in GLP-1 support, and virtual community groups with others on a similar journey. By pairing medical care with the GLP-1 Success framework, Med+ delivers a complete solution that goes far beyond prescription-only services-and drives stronger outcomes for members than medication alone. In addition, more than 70% of Weight Watchers Med+ members on the GLP-1 Success Program say that it helps them minimize weight loss medication side effects. For those who receive their GLP-1 prescriptions from an alternative medical provider, Weight Watchers is also offering the GLP-1 Success Program as a standalone option. These members receive the same comprehensive lifestyle, nutrition, movement, coaching, and community support as those on Med+, ensuring that anyone taking GLP-1s can access the structure and guidance needed to use these medications safely, effectively and successfully. The new experience will be gradually rolling across the global market in the coming weeks, starting on Dec. 26. The Weight Watchers app is available on both iOs and Android providing a seamless and modern interface across devices.